Source link : https://www.newshealth.biz/health-news/fda-approves-tarlatamab-for-extensive-stage-sclc/
The US Food and Drug Administration has granted accelerated approval to tarlatamab-dlle (Imdelltra, Amgen) for extensive-stage small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy. Tarlatamab is a first-in-class bispecific T-cell engager (BiTE) that binds delta-like ligand 3 on the surface of cells, including tumor cells, and CD3 expressed on the […]
Author : News Health
Publish date : 2024-05-16 22:20:50
Copyright for syndicated content belongs to the linked Source.
Categories